Tech Company Financing Transactions
RubrYc Therapeutics Funding Round
On 4/12/2018, RubrYc Therapeutics secured $10 million in Series A funding from Third Point, Paladin Capital Group and Vital Capital.
Transaction Overview
Company Name
Announced On
4/12/2018
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors
Proceeds Purpose
With our Series A financing, which completes our spin-off from HealthTell, Inc., we are continuing to build our antibody discovery platform, proprietary pipeline of therapeutic candidates, and actively initiating new pharmaceutical partnerships.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2420 Camino Ramon 125
San Ramon, CA 94583
USA
San Ramon, CA 94583
USA
Phone
Undisclosed
Website
Email Address
Overview
RubrYc Therapeutics, Inc., is a biotechnology solutions company using disruptive innovation to deliver fresh insights into the design and development of therapeutic antibodies.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Isaac Bright
Browse more venture capital transactions:
Prev: 4/12/2018: Aetion venture capital transaction
Next: 4/12/2018: Crayon venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs